In addition, anti-CCR8 CAR T cells exhibited antitumor activity against ATLL cells and CCR8-expressing T-ALL cells, and prolonged the survival of ATLL and Jurkat tumor-bearing mouse models. Here, CCR8 is linked to neoplasm.